Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Comprehensive Cancer Network

This publication has 30 references indexed in Scilit: